Form 4 for TDOC Teladoc Health, Inc.
Accepted 2025-06-11 00:00:00 ET · period of report 2025-06-10 · accession 0001347535-25-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-11 | 2025-06-10 | TDOC | DIVITA CHARLES III | CEO, Dir | M - OptEx | — | +156.6K | 156.6K | New | — |
| D | 2025-06-11 | 2025-06-10 | TDOC | DIVITA CHARLES III | CEO, Dir | M - OptEx | $0.00 | -156.6K | 313.3K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-10 | M | A | 156,641 | — | 156,641 | D | — | — | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Units | 2025-06-10 | M | D | 156,641 | $0.00 | 313,283 | D | — · — to — | 156,641 Common Stock | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F2) On June 10, 2024, the reporting person was granted 469,924 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |